A solid, supportive administrative team allows a network to run smoothly by providing support for meetings; developing and maintaining a platform for sharing documents; and ensuring communication is consistently provided to all members of the Network. The Duke/VUMC TIC provides administrative support to the Trial Innovation Network (TIN) to allow all of the TIN members including, TIC, RIC, CTSAs and NCATS to focus on the work that needs to occur for evaluating and testing innovative ideas and methods in clinical research.
The Duke/VUMC TIC currently provides administrative support to the Trial Innovation Network (TIN). This work is critical to TIN functionality and ensures the TIN is able to thoroughly evaluate and test innovative ideas and methods in clinical research. The proposed supplement will allow the TIN to continue to provide infrastructure support to promote collaboration, communication, and teamwork.
|Wang, Laura A; Smith, P Brian; Laughon, Matthew et al. (2018) Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants. Early Hum Dev 125:26-30|
|Gray, Keyaria D; Dudash, Kathryn; Escobar, Carla et al. (2018) Prevalence and safety of diazoxide in the neonatal intensive care unit. J Perinatol 38:1496-1502|
|Rivera-Chaparro, Nazario D; Ericson, Jessica; Wu, Huali et al. (2018) Safety, Effectiveness, and Exposure-Response of Micafungin in Infants: Application of an Established Pharmacokinetics Model to Electronic Health Records. Pediatr Infect Dis J :|
|Kumar, Karan R; Clark, David A; Kim, Evan M et al. (2018) Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants. J Pediatr 202:56-62.e2|
|Le, Jennifer; Poindexter, Brenda; Sullivan, Janice E et al. (2018) Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates. Ther Drug Monit 40:103-108|